Search

You searched for "outcome"

2510 results found

The use of toxin in paediatric strabismus

4 December 2025 | | EYE - Paediatrics
Strabismus is a common condition that affects up to 5% children and can be associated with abnormal visual development, double vision, loss of depth perception and impaired binocularity [1]. It can also cause cosmetic concerns, negatively impact psychosocial wellbeing and...

Post-Brexit deal welcomed but leaves future relationship with EU far from settled

6 April 2021 | | EYE - General
Rod McNeil breaks down the impact of the Brexit deal on healthcare in the UK, including medicines regulation, research funding, sharing of information and the ability to work abroad. A disorderly no-deal exit from the European Union (EU) was averted...

Lessons from an unusual case of syphilis

3 August 2023 | | EYE - Vitreo-Retinal
The rise of syphilis transmission rates over the past two decades has been one of public health’s great puzzles. In the UK, the situation has reached epidemic levels, with a 126% increase between 2013 and 2018 [1]. We present a...

VISION 2020 LINKS: COECSA Fellowship examination goes from strength to strength

1 April 2019 | | EYE - General
Eye health problems and access to diagnosis and treatment is an important issue throughout low- and middle-income countries (LMICs), and particularly on the African continent, where quality of life is drastically affected by poor vision, blindness and deteriorating eye health,...

Building capacity for diabetic retinopathy services in Malawi

1 August 2019 | | EYE - Vitreo-Retinal, EYE - General
Screening for diabetic retinopathy prevents blindness. There is no systematic screening programme for diabetic eye disease in Malawi and people present when they have lost vision and it is too late for treatment. The aim of the VISION 2020 LINK...

SOS (Simplified Ophthalmic Statistics) Part 2: How to summarise your data and why it’s a good idea to do so

1 August 2018 | | EYE - General
Studies involve capturing data. Statistical techniques allow data to be used to answer important research questions. A case series may have data on a handful of subjects but we are now entering the Big Data arena where datasets can be...

SpaMedica celebrates 15 years of industry innovation and unrivalled patient care

12 July 2023 | SpaMedica, anniversary, Industry
Launched in 2008, the UK’s largest provider of NHS cataract surgery has helped thousands of patients and invested in world-class training.

Doncaster eye hospital is rated ‘Outstanding’ by industry inspectors

17 October 2023 | SpaMedica, infrastructure, inspection, Cataract surgery
The independent regulator of health and social care in England has awarded a Doncaster eye hospital the highest possible rating - ‘Outstanding’ - following an inspection that took place in August 2023.

Moorfields to start new retinal detachment clinical trial

8 November 2023 | Moorfields, Funding, Phase I trial, Mahi Muqit, retinal detachment, proliferative vitreoretinopathy
Moorfields to start new retinal detachment clinical trial following £1.2 million MRC DPFS grant awarded to UCL and Moorfields Eye Hospital.

BCLA Presidential Address highlights the opportunities for growth in contact lens sector

15 December 2023 | BCLA, Rakesh Kapoor, Covid-19, UK
The new President of the BCLA has used his inaugural address to urge the sector to have “meaningful” conversations after eye exams and deliver “better vision outcomes” for patients.

Report: Kabgayi International Ophthalmology Conference 2024

27 March 2024 | events, international, congress, meeting, Africa, Rwanda, conference, report
My journey to Rwanda in April 2022 aimed to expand vitreoretinal services, but it also highlighted the need for robust scientific discourse, akin to the UK's ophthalmology culture, and so we seized the opportunity to plan an 'international' ophthalmology conference to coincide with a visit from five of my former UK consultant colleagues.

Booster accelerates EU-funded projects results to create tangible impact

2 December 2024 | EU-funded research, Dissemination, Exploitation, Commercialisation, Research exploitation, Horizon Europe programme, Impact, Research & Innovation, DG RTD
META Group is proud to announce that Booster has been renewed for another four years, with additional and customised services. Funded by the European Commission’s Directorate-General for Research and Innovation (DG RTD) and led by META Group, Booster offers a...